The incidence of isoniazid (INH) resistant is increasing globally. This study aimed to identify the molecular mechanisms behind the development of INH resistance in strains collected from the same patients during the standard course of treatment. Three strains were collected from a patient before and during antituberculosis (anti-TB) therapy.
View Article and Find Full Text PDF